Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Canada Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20022
20038
20044
20056
20065
20075
20088
20096
201013
20118
20126
20139
20146
20151
20166
20178
20184
20191
20202
20211
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated13
Unknown status3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S44
AstraZeneca12
Eli Lilly and Company9
Pfizer8
Laval University4
Allergan3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Population Health Research Institute3
Takeda3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus118
Diabetes Mellitus, Type 273
Diabetes Mellitus, Type 114
Glucose Metabolism Disorders9
Metabolic Diseases8
Cardiovascular Diseases7
Endocrine System Diseases7
Atherosclerosis6
Insulin Resistance6
Hypertension5

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.